胚乳
保健品
生物强化
生物技术
水稻
商业化
转基因水稻
转基因作物
转基因
生物
食品科学
化学
生物化学
业务
基因
营销
有机化学
锌
作者
Qinlong Zhu,Jiantao Tan,Yao‐Guang Liu
标识
DOI:10.1016/j.tibtech.2022.04.002
摘要
Plant expression platforms are low-cost, scalable, safe, and environmentally friendly systems for the production of recombinant proteins and bioactive metabolites. Rice (Oryza sativa L.) endosperm is an ideal bioreactor for the production and storage of high-value active substances, including pharmaceutical proteins, oral vaccines, vitamins, and nutraceuticals such as flavonoids and carotenoids. Here, we explore the use of molecular farming from producing medicines to developing functional food crops (biofortification). We review recent progress in producing pharmaceutical proteins and bioactive substances in rice endosperm and compare this platform with other plant expression systems. We describe how rice endosperm could be modified to design metabolic pathways and express and store stable products and discuss the factors restricting the commercialization of transgenic rice products and future prospects.
科研通智能强力驱动
Strongly Powered by AbleSci AI